SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Egan MF, Straub RE, Goldberg TE et al. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Proc. Natl Acad. Sci. USA 2004; 101: 12 604–12 609.
  • 2
    Norton N, Williams HJ, Dwyer S et al. No evidence for association between polymorphisms in GRM3 and schizophrenia. BMC Psychiatry 2005; 5: 23.
  • 3
    Tochigi M, Suga M, Ohashi J et al. No association between the metabotropic glutamate receptor type 3 gene (GRM3) and schizophrenia in a Japanese population. Schizophr. Res. 2006; 88: 260264.
  • 4
    Nicodemus KK, Kolachana BS, Vakkalanka R et al. Evidence for statistical epistasis between catechol-O-methyltransferase (COMT) and polymorphisms in RGS4, G72 (DAOA), GRM3, and DISC1: Influence on risk of schizophrenia. Hum. Genet. 2007; 120: 889906.
  • 5
    Albalushi T, Horiuchi Y, Ishiguro H et al. Replication study and meta-analysis of the genetic association of GRM3 gene polymorphisms with schizophrenia in a large Japanese case-control population. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007 Oct 19 [Epub ahead of print].
  • 6
    Watanabe Y, Fukui N, Muratake T et al. Association study of a functional promoter polymorphism of the X-box binding protein 1 gene in Japanese patients with schizophrenia. Psychiatry Clin. Neurosci. 2006; 60: 633635.
  • 7
    Fujii Y, Shibata H, Kikuta R et al. Positive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia. Psychiatr. Genet. 2003; 13: 7176.
  • 8
    Chen Q, He G, Chen Q et al. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population. Schizophr. Res. 2005; 73: 2126.
  • 9
    Bishop JR, Ellingrod VL, Moline J, Miller D. Association between the polymorphic GRM3 gene and negative symptom improvement during olanzapine treatment. Schizophr. Res. 2005; 77: 253260.